Recursion Pharmaceuticals Q3 EPS $(0.36) Misses $(0.31) Estimate, Sales $5.175M Miss $16.983M Estimate

Recursion Pharmaceuticals (NASDAQ: RXRX) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.31) by 16.88 percent. This is a 5.88 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $5.175 million which missed the analyst consensus estimate of $16.983 million by 69.53 percent. This is a 80.16 percent decrease over sales of $26.082 million the same period last year.